This inventor holds 15 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: The Broad Institute, Inc., The General Hospital Corporation, Massachusetts Institute of Technology. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (2015 - 2022)
- Austin, TX (US) (2015 - 2022)
- Dedham, MA (US) (2018 - 2022)
Company Filing History:
10 out of 490 
7 out of 3,080 
5 out of 8,608 
Years Active: 2015-2025
Areas of Expertise:
Title: The Innovative Mind of Michael C Lewis: A Look at His Contributions
Introduction
Michael C Lewis is an accomplished inventor based in Dedham, Massachusetts, with a remarkable portfolio of nine patents to his name. His work primarily focuses on advancements in the field of neuroscience and metabolism, showcasing his dedication to addressing critical health issues through innovative solutions.
Latest Patents
Among his latest patents, one notable invention is related to **Dopamine D2 receptor ligands**. This invention encompasses novel compounds aimed at providing functionally-biased dopamine D2 receptor ligands, which can be pivotal in treating or preventing a range of central nervous system and systemic disorders linked to dysregulation of dopaminergic activity.
Another significant patent involves **Inhibitors of histone deacetylase**. This invention introduces compounds designed to inhibit histone deacetylase, specifically selective HDAC3 inhibitors. These compounds are beneficial for protecting β-cells, improving insulin resistance, and promoting cognitive function. They are also applicable in treating various conditions, including metabolic disorders like type 1 and type 2 diabetes, liver diseases, neurological disorders, and more.
Career Highlights
Michael has made significant contributions during his tenure at renowned institutions such as the Broad Institute, Inc. and The General Hospital Corporation. His innovative work in these organizations has helped pave the way for advancements in medical and scientific research.
Collaborations
Collaboration is key in Michael's work, and he has partnered with noteworthy individuals in the field, including Edward Holson and Florence Fevrier Wagner. These collaborations have enabled him to leverage diverse expertise, enhancing the potential impact of his inventions.
Conclusion
In summary, Michael C Lewis exemplifies a dedicated inventor whose nine patents reflect a commitment to innovation in medical science. His groundbreaking work involving dopamine D2 receptor ligands and histone deacetylase inhibitors positions him as an influential figure tackling some of the most pressing health challenges today.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile